Difference between revisions of "Gastric adenocarcinoma and proximal polyposis of the stomach"

From Libre Pathology
Jump to: navigation, search
(+criteria)
(Criteria)
Line 7: Line 7:
 
==Criteria==
 
==Criteria==
 
Features - all required:<ref name=pmid30584346/>
 
Features - all required:<ref name=pmid30584346/>
*Polyps of stomach in body and fundus only.
+
*Polyps of stomach - body and fundus only.
 
**>100 polyps in index case ''or'' >30 polyps in first degree relative.
 
**>100 polyps in index case ''or'' >30 polyps in first degree relative.
**Histology predominantly [[fundic gland polyp]]s - some with dysplasia or adenocarcinoma.
+
**Histology predominantly [[fundic gland polyp]]s - some with dysplasia or adenocarcinoma in background.
 
*No colorectal or duodenal polyposis.
 
*No colorectal or duodenal polyposis.
 
*Autosomal dominant inheritance.
 
*Autosomal dominant inheritance.

Revision as of 11:47, 16 September 2019

Gastric adenocarcinoma and proximal polyposis of the stomach, abbreviated GAPPS, is a rare syndrome characterized by fundic gland polyps and gastric adenocarcinoma.[1][2]

General

  • Very rare.
  • APC promotor IB mutations.[1]

Criteria

Features - all required:[1]

  • Polyps of stomach - body and fundus only.
    • >100 polyps in index case or >30 polyps in first degree relative.
    • Histology predominantly fundic gland polyps - some with dysplasia or adenocarcinoma in background.
  • No colorectal or duodenal polyposis.
  • Autosomal dominant inheritance.
  • Exclusion of other heritable polyposis syndrome involving the stomach, PPI use.

See also

References

  1. 1.0 1.1 1.2 Rudloff, U. (2018). "Gastric adenocarcinoma and proximal polyposis of the stomach: diagnosis and clinical perspectives.". Clin Exp Gastroenterol 11: 447-459. doi:10.2147/CEG.S163227. PMID 30584346.
  2. Worthley, DL.; Phillips, KD.; Wayte, N.; Schrader, KA.; Healey, S.; Kaurah, P.; Shulkes, A.; Grimpen, F. et al. (May 2012). "Gastric adenocarcinoma and proximal polyposis of the stomach (GAPPS): a new autosomal dominant syndrome.". Gut 61 (5): 774-9. doi:10.1136/gutjnl-2011-300348. PMID 21813476.